$30 Billion Deal, page-4518

In my mind delays only mean 2 things... CRO still not complete and everyone somewhat in the dark ..... OR .... results are being analysed subject to NDA both internally (advisory board) & externally BP. If one of the trials was a total flop (ie BP walk away from interest/discussions) without trading halt then this would flow back through to the market quite quickly and SP would show much more weakness. Current market shows Biotron is very tight ship and their unwillingness to share any further information or updates is creating perfect breeding for impatient/frustrated retailers to sell.